If SEAMLESS Phase 3 has shown the alightest positive developments this will go hay wire. DSMB had no safety issues and urged they continue trials as finding will only appear in the latter stages.
Remember Johnson and Johnson's Decitabin? they were approved in Europe-US off lab and revenues are huge!! They showed no significant improvements but rather a trend which is what Cyclacel has showed this far.
(0)
(0)
Cyclacel Pharmaceuticals Inc. (CYCC) Stock Research Links